Showing results (1-10 of 463) with videos related to
Sort By:
Pageof 47
Expert Opinion on Drug Discovery|September 14, 2020
Challenges with matrix metalloproteinase inhibition and future drug discovery avenuesThomas Fischer, Rainer RiedlChemistryopen|April 18, 2017
Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase InhibitorThomas Fischer, Rainer RiedlMolecules (Basel, Switzerland)|September 23, 2020
Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 InhibitorThomas Fischer, Rainer RiedlDrug Discovery Today|October 22, 2021
Paracelsus' legacy in the faunal realm: Drugs deriving from animal toxinsThomas Fischer, Rainer RiedlMolecules (Basel, Switzerland)|June 21, 2019
Inhibitory Antibodies Designed for Matrix Metalloproteinase ModulationThomas Fischer, Rainer RiedlChemistryopen|April 18, 2017
Targeted Fluoro Positioning for the Discovery of a Potent and Highly Selective Matrix Metalloproteinase InhibitorThomas Fischer, Rainer RiedlInternational Journal of Molecular Sciences|March 4, 2016
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand EfficienciesThomas Fischer, Rainer RiedlExpert Opinion on Drug Discovery|June 11, 2019
Approaching Target Selectivity by De Novo Drug DesignThomas Fischer, Silvia Gazzola, Rainer RiedlChemistry (Weinheim an Der Bergstrasse, Germany)|February 6, 2019
Design and Structural Evolution of Matrix Metalloproteinase InhibitorsThomas Fischer, Nicole Senn, Rainer RiedlArchiv Der Pharmazie|December 9, 2024
Phthalimide derivatives as a new class of papain-like protease inhibitors in SARS-CoV-2Thomas Fischer, David Frasson, Martin Sievers, et al.Pageof 47